WO2025099639 - COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS
National phase entry is expected:
Publication Number
WO/2025/099639
Publication Date
15.05.2025
International Application No.
PCT/IB2024/061053
International Filing Date
07.11.2024
Title **
[English]
COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS
[French]
COMPOSITIONS ET MÉTHODES DE TRAITEMENT D'AFFECTIONS CUTANÉES
Applicants **
SULUR, Vishagan Vanangamudi
Inventors
SULUR, Vanangamudi Subramaniam
LAKSHMI, Ramanathan Narayanan
Priority Data
63/597,279
08.11.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4269 | |
| EPO | Filing, Examination, Granting | 46070 | |
| Japan | Filing, Examination, Granting | 4216 | |
| South Korea | Filing, Examination, Granting | 5801 | |
| USA | Filing, Examination, Granting | 25540 |
Total:
85,896
Abstract[English]
Provided herein are compositions for topical application to a subject, for treating epidermolysis bullosa (EB). Also disclosed are methods for treating skin in a person suffering from EB. The methods comprise providing a composition comprising fusidic acid and one or more pharmaceutically acceptable excipients; and topically applying, or instructing to topically apply, the composition to skin of a person suffering from EB. In some embodiments, the composition is topically administered to treat a non-healing wound, chronic wound or lesional skin in a patient suffering from EB, to reduce the likelihood of skin infections, to reduce the likelihood of scar formation, to prevent or reduce the risk of a skin blister from becoming infected, to treat intact blisters on skin, to treat skin dysbiosis, to alter bacterial diversity of the skin microbiome, or to increase the quality of life in a subject suffering from EB.[French]
L'invention concerne des compositions pour une application topique à un sujet, pour le traitement de l'épidermolyse bulleuse (EB). Sont également divulguées des méthodes de traitement de la peau chez une personne souffrant d'EB. Les méthodes comprennent la fourniture d'une composition comprenant de l'acide fusidique et un ou plusieurs excipients pharmaceutiquement acceptables ; et l'application par voie topique, ou l'instruction d'appliquer par voie topique, la composition sur la peau d'une personne souffrant d'EB. Dans certains modes de réalisation, la composition est administrée par voie topique pour traiter une plaie ne cicatrisant pas, une plaie chronique ou une peau lésionnelle chez un patient souffrant d'EB, pour réduire la probabilité d'infections cutanées, pour réduire la probabilité de formation de cicatrice, pour prévenir ou réduire le risque d'infection d'une ampoule cutanée, pour traiter des ampoules intactes sur la peau, pour traiter une dysbiose de la peau, pour modifier la diversité bactérienne du microbiome cutané ou pour augmenter la qualité de vie d'un sujet souffrant d'EB.